BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15304178)

  • 1. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
    Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R
    Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
    de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
    Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy and confinement due to leprosy show high association with hepatitis C in Southern Brazil.
    de Moraes Braga AC; Reason IJ; Maluf EC; Vieira ER
    Acta Trop; 2006 Jan; 97(1):88-93. PubMed ID: 16263074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
    Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
    Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
    Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
    Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
    Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
    Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
    Schuval S; Van Dyke RB; Lindsey JC; Palumbo P; Mofenson LM; Oleske JM; Cervia J; Kovacs A; Dankner WN; Smith E; Nowak B; Ciupak G; Webb N; Eagle M; Smith D; Hennessey R; Goodman-Kerkau M; Levin MJ;
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):1007-13. PubMed ID: 15466691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
    Treviño A; García J; de Mendoza C; Benito R; Aguilera A; Ortíz de Lejarazu R; Ramos JM; Trigo M; Eirós JM; Rodríguez-Iglesias M; Torres A; Calderón E; Hernandez A; Gomez C; Marcaida G; Soriano V;
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):861-4. PubMed ID: 20672999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma.
    Kamihira S; Yamada Y; Sohda H; Atogami S; Tomonaga M; Egawa S; Fujii M; Chifu K
    Cancer Detect Prev; 1994; 18(5):329-34. PubMed ID: 7812978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
    Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
    Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
    Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.